In-stent restenosis in the drug-eluting stent era
The introduction of the drug-eluting stent (DES) proved to be an important step forward in
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force …
SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier
The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …
make recommendations about appropriate use of technology for the diagnosis and …
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
ContextTraditionally, stent thrombosis has been regarded as a complication of percutaneous
coronary interventions during the first 30 postprocedural days. However, delayed …
coronary interventions during the first 30 postprocedural days. However, delayed …
Molecular basis of restenosis and drug-eluting stents
MA Costa, DI Simon - Circulation, 2005 - Am Heart Assoc
Next is a granulation or cellular proliferation phase. Growth factors are subsequently
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart …
WRITING COMMITTEE MEMBERS, SC Smith Jr… - Circulation, 2006 - Am Heart Assoc
that support either the 2001 recommendations that have changed or the new or revised
recommendations are cited in parentheses at the end of each recommendation or comment …
recommendations are cited in parentheses at the end of each recommendation or comment …
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents
AV Finn, FD Kolodgie, J Harnek, LJ Guerrero… - Circulation, 2005 - Am Heart Assoc
Background—Although effective coverage of challenging coronary lesions has warranted
the use of overlapping drug-eluting stents, the histopathological response to stent overlap is …
the use of overlapping drug-eluting stents, the histopathological response to stent overlap is …
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
F Airoldi, A Colombo, N Morici, A Latib, J Cosgrave… - Circulation, 2007 - Am Heart Assoc
Background—The need for prolonged aspirin and thienopyridine therapy and the risk of
stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents. Methods …
stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents. Methods …
Early and mid-term results of drug-eluting stent implantation in unprotected left main
A Chieffo, G Stankovic, E Bonizzoni, E Tsagalou… - Circulation, 2005 - Am Heart Assoc
Background—The safety and efficacy of percutaneous coronary intervention in unprotected
left main (ULM) coronary arteries are still a matter of debate. Methods and Results—All …
left main (ULM) coronary arteries are still a matter of debate. Methods and Results—All …
Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation
MK Hong, GS Mintz, CW Lee, DW Park… - European heart …, 2006 - academic.oup.com
Aims In many countries, drug-eluting stent implantation is the dominant interventional
strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound …
strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound …
Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience
Background—Improvements in results with percutaneous coronary intervention (PCI) with
drug-eluting stents (DES) may extend their use in patients with left main coronary artery …
drug-eluting stents (DES) may extend their use in patients with left main coronary artery …